Skip to main content
. 2024 Jun 11;14:1419256. doi: 10.3389/fonc.2024.1419256

Figure 3.

Figure 3

Forest plot and pooled odds ratio of ILD caused by EGFR-TKI in all patients (A, B) and in Asian patients (C, D) with/without VEGF/VEGFR inhibitors. EGFR, epidermal growth factor receptor; ILD, interstitial lung disease; TKI, tyrosine kinase inhibitor; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor.